-
Views
-
Cite
Cite
1 April News, Clinical Infectious Diseases, Volume 54, Issue 7, 1 April 2012, Pages i–ii, https://doi.org/10.1093/cid/cis129
Close - Share Icon Share
Extract
Food and Drug Administration to Protect Important Class of Antimicrobial Drugs for Treating Human Illness
4 January 2012 (Food and Drug Administration news release)—The US Food and Drug Administration (FDA) today issued an order that prohibits certain uses of the cephalosporin class of antimicrobial drugs in cattle, swine, chickens, and turkeys effective 5 April 2012. This new order takes into consideration the substantial public comment the FDA received on a similar order that it issued in 2008 but revoked before implementation. The FDA is taking this action to preserve the effectiveness of cephalosporin drugs for treating disease in humans.
In its order, the FDA is prohibiting what are called “extralabel” or unapproved uses of cephalosporins in cattle, swine, chickens, and turkeys. Specifically, the prohibited uses include (1) using cephalosporin drugs at unapproved dose levels, frequencies, durations, or routes of administration; (2) using cephalosporin drugs in cattle, swine, chickens, or turkeys that are not approved for use in that species (eg, cephalosporin drugs intended for humans or companion animals); and (3) using cephalosporin drugs for disease prevention.
